These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17472700)

  • 1. Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells.
    Kyratzi E; Pavlaki M; Kontostavlaki D; Rideout HJ; Stefanis L
    J Neurochem; 2007 Aug; 102(4):1292-303. PubMed ID: 17472700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress.
    Seki T; Takahashi H; Adachi N; Abe N; Shimahara T; Saito N; Sakai N
    Eur J Neurosci; 2007 Dec; 26(11):3126-40. PubMed ID: 18005063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
    Korutla L; Furlong HA; Mackler SA
    Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
    Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
    Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
    Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
    Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells.
    Koch A; Lehmann-Horn K; Dächsel JC; Gasser T; Kahle PJ; Lücking CB
    Parkinsonism Relat Disord; 2009 Mar; 15(3):220-5. PubMed ID: 18586549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.
    Rosen KM; Moussa CE; Lee HK; Kumar P; Kitada T; Qin G; Fu Q; Querfurth HW
    J Neurosci Res; 2010 Jan; 88(1):167-78. PubMed ID: 19610108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin E3 ligase Parkin regulates neuronal Ca
    Grimaldo L; Sandoval A; Duran P; Gómez Flores-Ramos L; Felix R
    J Neurophysiol; 2022 Dec; 128(6):1555-1564. PubMed ID: 36350063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
    Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
    Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function.
    Tsai YC; Fishman PS; Thakor NV; Oyler GA
    J Biol Chem; 2003 Jun; 278(24):22044-55. PubMed ID: 12676955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.
    Schlossmacher MG; Shimura H
    Methods Mol Biol; 2005; 301():351-69. PubMed ID: 15917645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular parkin mutants are soluble under non-stress conditions.
    Jensen LD; Vinther-Jensen T; Kahns S; Sundbye S; Jensen PH
    Neuroreport; 2006 Jul; 17(11):1205-8. PubMed ID: 16837855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
    Lim KL; Dawson VL; Dawson TM
    Neurobiol Aging; 2006 Apr; 27(4):524-9. PubMed ID: 16213628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin.
    Um JW; Han KA; Im E; Oh Y; Lee K; Chung KC
    J Neurosci Res; 2012 May; 90(5):1030-42. PubMed ID: 22271254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein.
    Kemeny S; Dery D; Loboda Y; Rovner M; Lev T; Zuri D; Finberg JP; Larisch S
    PLoS One; 2012; 7(7):e38837. PubMed ID: 22792159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.
    Hyun DH; Lee M; Halliwell B; Jenner P
    J Neurosci Res; 2005 Oct; 82(2):232-44. PubMed ID: 16130151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.